Millennium Molecular Pathology Private Limited
About Millennium Molecular Pathology Private Limited
Data last updated:
Millennium Molecular Pathology Private Limited was a private limited company based in Pune, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the nursing segment of the healthcare sector. It was incorporated on 19 November 2007.
The company was registered with the Registrar of Companies (ROC), Pune, under CIN U85110PN2007PTC131003.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Anjali Sadashiv Bordawekar and Shalaka Rajiv Bordawekar.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at Office No. 10 11 12 First Floor N K Image Near Grahak Peth Sadashiv Peth, Pune, Maharashtra, India – 411030.
As per the financials filed for FY 2023, the company reported a revenue of ₹25,951. For the same year it recorded a net profit of ₹22,765 (net margin 87.7%) and EBITDA of ₹25,951 (EBITDA margin 100%). Revenue has declined at a compounded annual rate (CAGR) of 72% over three years and 52% over five years.
Company details
Contact details
Millennium Molecular Pathology Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressOffice No. 10 11 12 First Floor N K Image Near Grahak Peth Sadashiv Peth, Pune, Maharashtra, India – 411030
- IndustryHealthcare, Nursing, Pathology, Dentalcare
To see the full contact details of Millennium Molecular Pathology Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Millennium Molecular Pathology is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
Financials of Millennium Molecular Pathology Private Limited
FY 2023 filings availableMillennium Molecular Pathology Private Limited reported revenue of ₹25,951 for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 52% over five years. EBITDA rose 209% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹25,951 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹22,765 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 100% | ||||
| Net Profit Margin | 87.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Millennium Molecular Pathology Private Limited, buy the company report.
Board of directors of Millennium Molecular Pathology Private Limited
Millennium Molecular Pathology has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anjali Sadashiv Bordawekar | Director | 02 Mar 2016 | 10 Years 7 Months | As last reported |
| Shalaka Rajiv Bordawekar | Director | 19 Nov 2007 | 18 Years 11 Months | As last reported |
Peer comparison
Millennium Molecular Pathology Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nemmara Hospital and Medical Institute Private Limited | ₹30,000 (FY 2023) | -98.0% | Palakkad, Kerala, India | |||
| Orthopod Online Private Limited | ₹28,650 (FY 2025) | 124.0% | Mumbai, Maharashtra, India | |||
| Lifeboat Healthcare Private Limited | ₹28,000 (FY 2018) | 40.0% | Gurgaon, Haryana, India | |||
| Kunjai Pharmaceuticals Private Limited | ₹26,640 (FY 2024) | 5.0% | Jhunsi, Uttar Pradesh, India | |||
| Vow for Red Foundations | ₹26,001 (FY 2024) | 8.0% | Allahabad, Uttar Pradesh, India | |||
| Millennium Molecular Pathology Private Limitedthis company | ₹25,951 (FY 2023) | ₹22,765 | 87.7% | Pune, Maharashtra, India | ||
| Panacea Medical Research and Diagnostic Centre Private Limited | ₹25,160 (FY 2024) | -59.0% | Guwahati, Assam, India | |||
| Serampore Matrisadan Private Limited | ₹24,500 (FY 2018) | -12.0% | Kolkata, West Bengal, India | |||
| Atul X-Ray and Lab Private Limited | ₹23,307 (FY 2019) | -99.0% | New Delhi, Delhi, India | |||
| Mediwin Diagnostic Centre Private Limited | ₹22,837 (FY 2025) | -100.0% | North 24 Parganas, West Bengal, India | |||
| First Blue Healthcare Private Limited | ₹20,590 (FY 2022) | Chennai, Tamil Nadu, India |
To see the full peer comparison of Millennium Molecular Pathology Private Limited, buy the company report.
Auditor
Millennium Molecular Pathology Private Limited is audited by ABHAY GUNDECHA & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ABHAY GUNDECHA & CO. | FY 2017 | 112772W |
Shareholding
The shareholding of Millennium Molecular Pathology Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Millennium Molecular Pathology Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Millennium Molecular Pathology Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Millennium Molecular Pathology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Millennium Molecular Pathology Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Millennium Molecular Pathology Private Limited has 3 board changes on record since 2007: 2 appointments and 1 cessation. The latest: Nihalchand Uttamchand Gandhi ceased to be Director on 07 Mar 2016.
Frequently asked questions
Millennium Molecular Pathology has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Millennium Molecular Pathology was a private limited company based in Pune, Maharashtra, India. The company worked in nursing, within the healthcare industry. It was incorporated on 19 November 2007 and is registered under CIN U85110PN2007PTC131003. The company has been struck off by the Registrar of Companies and is no longer operational.
Millennium Molecular Pathology had 2 directors:
- Anjali Sadashiv Bordawekar - Director
- Shalaka Rajiv Bordawekar - Director
The CIN (Corporate Identification Number) of Millennium Molecular Pathology is U85110PN2007PTC131003. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Millennium Molecular Pathology is at Office No. 10 11 12 First Floor N K Image Near Grahak Peth Sadashiv Peth, Pune, Maharashtra, India – 411030.
Millennium Molecular Pathology was incorporated on 19 November 2007. It is registered with the Registrar of Companies, Pune.
The latest financial statements of Millennium Molecular Pathology on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
Millennium Molecular Pathology operated in the healthcare industry, in the nursing segment. It worked in this industry before it was struck off.
The peers of Millennium Molecular Pathology by revenue are Nemmara Hospital and Medical Institute Private Limited, Orthopod Online Private Limited, Lifeboat Healthcare Private Limited, Kunjai Pharmaceuticals Private Limited, Vow for Red Foundations and 5 more, all in the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.).
Nihalchand Uttamchand Gandhi ceased to be Director on 07 Mar 2016. Anjali Sadashiv Bordawekar was appointed as Director on 02 Mar 2016. Shalaka Rajiv Bordawekar was appointed as Director on 19 Nov 2007.
The compliance status of Millennium Molecular Pathology is compliant as of 03 August 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
